Mersana Therapeutics Inc (MRSN)
2.725
+0.14
(+5.62%)
USD |
NASDAQ |
May 17, 16:00
2.725
0.00 (0.00%)
Pre-Market: 20:00
Mersana Therapeutics Accounts Receivable (Quarterly)
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 30.00M |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 0.00 |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 |
| Date | Value |
|---|---|
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | 0.298M |
| June 30, 2019 | 0.288M |
| March 31, 2019 | 0.468M |
| December 31, 2018 | 0.459M |
| September 30, 2018 | 0.586M |
| June 30, 2018 | 1.681M |
| March 31, 2018 | 0.288M |
| December 31, 2017 | 0.784M |
| September 30, 2017 | 0.731M |
| June 30, 2017 | 0.513M |
| March 31, 2017 | 0.712M |
| December 31, 2016 | 1.051M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2021
30.00M
Maximum
Dec 2022
3.823M
Average
--
Median
Dec 2021
Accounts Receivable (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 76.43M |
| Geron Corp | -- |
| Insmed Inc | 37.16M |
| Altimmune Inc | 0.307M |
| InfuSystems Holdings Inc | 20.54M |